Non-Specific Urethritis (NSU) in Malaysia: Symptoms, Testing & Treatment
Non-specific urethritis (NSU) - also called non-gonococcal urethritis (NGU) - is inflammation of the urethra not caused by gonorrhoea. Common culprits include chlamydia (40-50%), Mycoplasma genitalium and Ureaplasma. Standard treatment is a short oral antibiotic course; persistent NSU requires Mycoplasma genitalium testing with resistance profiling and a guideline-directed second-line antibiotic.
Medically reviewed by Dr. Azzim Emir · MBChB, MMC-registered · Pathogen: Mixed - Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Trichomonas, adenoviruses; ~20-30% truly idiopathic · ICD-10 N34.1

What is non-specific urethritis (nsu)?
Non-specific urethritis (NSU) is a clinical diagnosis applied when a man (or person with a penis) has urethral inflammation - discharge, burning urination, urethral discomfort - but tests negative for gonorrhoea. The term covers a mix of identified and unidentified pathogens.
Most NSU is caused by an STI even when no specific organism is found, so it is treated empirically. Persistent or recurrent NSU points to Mycoplasma genitalium until proven otherwise.
Pathogen: Mixed - Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Trichomonas, adenoviruses; ~20-30% truly idiopathic (Multiple - bacterial and viral).
How it spreads
- Unprotected vaginal, anal or oral sex (most common cause)
- Some cases are non-sexually acquired (UTI, urethral trauma, irritation)
- Sharing sex toys without barrier protection
Who is at risk? Should I get tested?
- Sexually active men under 35
- New or multiple partners in past 6 months
- Inconsistent condom use
- Previous STI or persistent urethral symptoms
- Partner recently treated for chlamydia or gonorrhoea
Should I get tested? Quick self-check
Answer the questions below - your concierge can advise on the next step.
- Do you have urethral discharge that is clear, white or cloudy?
- Do you have burning or stinging during urination?
- Have you had unprotected sex in the past 6 weeks?
- Have your symptoms persisted after a previous antibiotic course?
- Has a partner been diagnosed with chlamydia, gonorrhoea or Mycoplasma genitalium?
Symptoms
- Clear, white or cloudy urethral discharge (often mild)
- Burning or stinging during urination
- Itching, tickling or discomfort in the urethra
- Urethral meatus redness
- Mild testicular ache (epididymitis if untreated)
- Often less dramatic than gonococcal urethritis
Asymptomatic in men
By definition NSU is symptomatic urethritis - but the underlying organism (e.g. Mycoplasma genitalium, Ureaplasma) is often silent in partners
Asymptomatic in women
Female partners commonly carry the causative organism without urethral symptoms but may develop pelvic inflammatory disease
Source: see reference [1] below.
Malaysia statistics
| NSU is one of the most common reasons for sexual health consultations among Malaysian men | [2] |
| Chlamydia trachomatis identified in NSU cases | ~40-50%[1] |
| Mycoplasma genitalium identified in NSU cases | ~10-30%[1] |
| Truly idiopathic NSU (no organism identified) | ~20-30%[1] |
| Recurrence/persistence rate after first-line treatment | ~10-20% (often M. genitalium)[1] |
Testing & window period
Method
NAAT (PCR) for chlamydia, gonorrhoea and Mycoplasma genitalium. Urethral smear for leukocytes if available. Urine dipstick to exclude UTI.
Specimen
First-void urine; urethral swab if discharge is present
Window period
Test as soon as symptoms appear. If exposure was within 7 days and tests negative, repeat at 1-2 weeks.
Retest
Test of cure at 4 weeks if Mycoplasma genitalium was identified or if symptoms persist after treatment.
Treatment
First-line: A short oral antibiotic course covering chlamydia and most NSU pathogens, started empirically by our medical team while awaiting laboratory results.
Alternative: Alternative oral regimens are available where the first-line antibiotic is unsuitable. If Mycoplasma genitalium is confirmed, treatment is resistance-guided - the specific antibiotic is selected at consultation based on the macrolide-resistance result.
Partner management: Partners from the past 60 days should be tested for chlamydia, gonorrhoea and M. genitalium, and treated presumptively for chlamydia.
Abstain from sex for 7 days after treatment and until all partners are treated.
Follow-up
- Review at 3-4 weeks - if symptoms persist, retest for M. genitalium and consider second-line therapy
- Test of cure mandatory if M. genitalium was identified
- Screen for other STIs - HIV, syphilis, hepatitis
Prevention
- Consistent condom use for vaginal, anal and oral sex
- Avoid sharing sex toys
- Partner notification and concurrent treatment
- Routine STI screening every 3-6 months if multiple partners
- Do not self-treat - empirical antibiotics without M. genitalium testing drives resistance
Vaccination
No vaccine exists for NSU pathogens.
See also: Mycoplasma genitalium info, Chlamydia info, STI testing options
Non-Specific Urethritis (NSU) - frequently asked questions
Clear answers, written by our clinical team. Tap any question for its direct permalink, or reach out to your Personal Concierge for anything else.
Both cause urethritis. Gonorrhoea is caused specifically by Neisseria gonorrhoeae and tends to produce thicker, often green/yellow discharge. NSU covers all other causes - most commonly chlamydia and Mycoplasma genitalium - with milder discharge and burning.
Still have a question?
Your Personal Concierge replies within one business day - confidentially.
References
- [1] BASHH UK. Non-specific urethritis (NSU) and non-gonococcal urethritis guideline.
- [2] Ministry of Health Malaysia. STI/HIV Sector clinical practice guidelines.
- [3] Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines, 2021.
Other STI conditions
Browse our other in-depth STI guides - each covers symptoms, asymptomatic statistics by sex, Malaysia data, testing windows, treatment and prevention.
Your personal health concierge
One dedicated contact coordinates your testing, treatment, partner support and follow-up - discreetly and end-to-end. All care is delivered by our MMC-registered medical team.